Zimmer Biomet Holdings, Inc. (ZBH) Shares Bought by Private Wealth Advisors Inc.

Private Wealth Advisors Inc. lifted its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 9.5% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,030 shares of the medical equipment provider’s stock after purchasing an additional 610 shares during the quarter. Private Wealth Advisors Inc.’s holdings in Zimmer Biomet Holdings were worth $903,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Enterprise Financial Services Corp boosted its position in shares of Zimmer Biomet Holdings by 0.3% in the 2nd quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after purchasing an additional 9 shares during the period. Sandy Spring Bank boosted its position in shares of Zimmer Biomet Holdings by 1.7% in the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after purchasing an additional 20 shares during the period. Parkside Financial Bank & Trust boosted its position in shares of Zimmer Biomet Holdings by 2.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock valued at $102,000 after purchasing an additional 22 shares during the period. Cleararc Capital Inc. boosted its position in shares of Zimmer Biomet Holdings by 0.5% in the 1st quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after purchasing an additional 25 shares during the period. Finally, Palladium Partners LLC boosted its position in shares of Zimmer Biomet Holdings by 1.7% in the 2nd quarter. Palladium Partners LLC now owns 2,501 shares of the medical equipment provider’s stock valued at $321,000 after purchasing an additional 41 shares during the period. 85.35% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This story was published by BBNS and is the sole property of of BBNS. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at https://baseballnewssource.com/markets/private-wealth-advisors-inc-has-903000-stake-in-zimmer-biomet-holdings-inc-zbh/1602760.html.

A number of brokerages recently issued reports on ZBH. Gabelli began coverage on Zimmer Biomet Holdings in a research report on Thursday, August 24th. They issued a “buy” rating and a $142.00 target price for the company. Oppenheimer Holdings, Inc. set a $137.00 target price on Zimmer Biomet Holdings and gave the company a “buy” rating in a research report on Monday, August 14th. Zacks Investment Research cut Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 8th. BidaskClub cut Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Finally, BMO Capital Markets upped their target price on Zimmer Biomet Holdings from $136.00 to $140.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $136.58.

Zimmer Biomet Holdings, Inc. (ZBH) opened at 114.40 on Friday. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49. The stock’s 50 day moving average price is $114.50 and its 200-day moving average price is $120.75. The stock has a market capitalization of $23.13 billion, a P/E ratio of 32.58 and a beta of 1.21.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The firm had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.95 billion. During the same period in the previous year, the firm earned $2.02 EPS. Zimmer Biomet Holdings’s revenue for the quarter was up 1.1% on a year-over-year basis. Equities research analysts expect that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be issued a $0.24 dividend. The ex-dividend date is Thursday, September 21st. This represents a $0.96 annualized dividend and a dividend yield of 0.84%. Zimmer Biomet Holdings’s dividend payout ratio is currently 27.59%.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of the company’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $121.74, for a total value of $2,067,875.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.07% of the stock is currently owned by corporate insiders.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.